However, there is also evidence to suggest that BOP1 is a downstream target of the WNT/beta-catenin pathway in colorectal cancer cells [71], suggesting that additional studies are required to further understand the role of BOP1 in cancer stem cells. This evidence concerns the gene CTNNB1 and colorectal cancer.